Wang, L-T., Chiou, S-S., Chai, C-Y., Hsi, E., Chiang, C-M., Huang, S-K., Wang, S-N., Yokoyama K., and Hsu, S-H: Transcription factor SPZ1 promotes TWIST-mediated wpithelial-mescenchymal transition and oncogenesis in human liver cancer. Oncogene, 36, 4405-4414 (2017).

Wuputra, K.,Tsai, M-H., Ku, C-C., Lin W-H., Kuo K-K., Lin C-S., and Yokoyama K.: Cancer cell reprogramming to identify the genes competent for generating liver cancer stem cells. Inflammation and Regeneration, 37, 15; DOI:10.1186/s41232-0041-x (2017).

Wang, L-T., Chiou, S-S., Chai, C-Y., Esi, E., Yokoyama, K., Wang, S-N*, Hunag, S-K*, and Hsu, S-H*: Intestine-sepcific homeobox gene, ISX, integrates IL-6 signaling, tryptophan metaboplism and immune suppression. Cancer Res., 77, 4065-4071 (2017).

Kuo, T-F., Chen, T-Y., Jiang, S-T., Chen, K-W., Chiang, Y-M., Hsu, Y-J., Liu, Y-J., Chen, H-M., Yokoyama, K., Tsai, K-C., Yeh, H-H., Chen, Y-R., and Yang, W-C.*: Protein disulfide isomerase a4 is required for tumorigenesis in mouse models of cancer. Oncogene, 36, 5484-5496 (2017).

Pan, X-Y., Tsai, M-H., Wuputra, K., Ku, C-C., Lin, W-H., Lin, Y-C., Kishikawa, S., Noguchi, M., Saito, S., Lin, C-S., and *Yokoyama K.: Application of Cancer Cell Reprogramming Technology to Human Cancer Research. Anticancer Research, 37, 3367-3377.

Wu, D-C., Wang, S S-W., Liu, C-J., Wuputra, K., Lee Y-L., Lin Y-C., Tsai, M-H., Ku, C-C., Lin, W-H., Wang, S-W., Kishikawa, S., Noguchi, M., Chai, C-Y., Lin, C-L., Kuo, K-K., Yang, Y-H., Muyishi, H., Nakamura, Y., Saito, S., Lin, C-S.*, and Yokoyama K.*: reprogramming antagonizes the Oncogenicity of HOXA13-Long noncoding RNA HOTTIP axis in gastric cells. Stem Cells, 35, 2115-2128 (2017).

Nakade, K., Lin, C-S., Chen, X-Y., Tsai, M-H., Wuputra, K., Zhu, Z-W., *Pan, J-Z., and *Yokoyama, K.: JDP2 controls the hypoxia induced replicative senescence via both the p16Ink4a-pRb and Arf-p53 pathweays. FEBS Open Bio, 7, 1793-1804 (2017).